Speeding up Treatment Decisions for Blood Cancer Patients

June 8, 2015 Brigham and Women's Hospital

Genetic mutations associated with certain blood cancers can be detected by testing blood or bone marrow samples.

For patients with aggressive types of leukemia and other blood cancers, quickly identifying and starting the right treatment can make all the difference. In a major advance in the care of these patients, physicians at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have begun using the Rapid Heme Panel, a high-tech genetic test that provides, within a week, an unprecedented amount of critical information to aid the choice of treatment.

In this video, Dr. Jon Aster, Director of Hematopathology at Brigham and Women’s Hospital (BWH) and one of the developers of the Rapid Heme Panel, explains how the test uses blood or bone marrow samples to search for alterations in genes that are frequently associated with leukemias and myeloproliferative disorders – detecting key mutations that determine prognosis and the specific drugs the cancer is most likely to respond to. The Rapid Heme Panel testing is performed at the Center for Advanced Molecular Diagnostics at BWH.

Related Links:

Previous Article
From the Dentist’s Chair to the Delivery Room – Nitrous Oxide for Relief of Labor Pain
From the Dentist’s Chair to the Delivery Room – Nitrous Oxide for Relief of Labor Pain

Today’s post is written by Dr. Bill Camann, Director of Obstetric...

Next Article
Growing New Cartilage in Novel Clinical Research Study

An active 34-year-old and new father, Sean has been sidelined from physical...